Security key
14159C202
Cardio Diagnostics Holdings, Inc. - COM NEW (CDIO)
CUSIP: 14159C202
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 84,726
- Total 13F value
- $305,010
- Share change
- +84,726
- SEC-reported price per share
- $3.60
- Number of holders
- 15
- Value change
- +$305,010
- Number of buys
- 15
Report period
Q2 2025
Institutions
15
Top holders
10
CDIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Cardio Diagnostics Holdings, Inc. SEC filings
Cardio Diagnostics Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14159C202
Recent filing periods:
Ownership snapshot
Top reported holders of CDIO - Cardio Diagnostics Holdings, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Meeshanthini Dogan
Disclosed value leader
Meeshanthini Dogan
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5
13F
Highest disclosed value: $4,424,560
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Meeshanthini Dogan has the largest disclosed position value at $4.42M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Meeshanthini Dogan's linked filing trail.
Disclosed position value
Top 5
Meeshanthini Dogan
$4.42M
Timur Dogan
$4M
Robert Philibert
$2.18M
Warren Hosseinion
$1.06M
Khullani Abdullahi
$641.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Meeshanthini Dogan |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$4,424,560
3,524,854 shares
mixed-class rows
|
— | 06 Sep 2024 |
| Timur Dogan |
3/4/5
Chief Technology Officer
|
—
mixed-class rows
|
$4,001,706
2,066,735 shares
mixed-class rows
|
— | 06 Sep 2024 |
| Robert Philibert |
3/4/5
Chief Medical Officer, Director
|
—
mixed-class rows
|
$2,179,096
2,489,332 shares
mixed-class rows
|
— | 06 Sep 2024 |
| Warren Hosseinion |
3/4/5
Director
|
—
class O/S missing
|
$1,059,631
502,195 shares
|
— | 23 Jan 2024 |
| Khullani Abdullahi |
3/4/5
VP of Revenue and Strategy
|
—
class O/S missing
|
$641,710
304,128 shares
|
— | 23 Jan 2024 |
| Elisa Luqman V |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
$558,796
264,832 shares
|
— | 23 Jan 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
84,726
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2026 Across Filers
Q1 2026 holders
16
Q2 2025 holders
15
Holder diff
-1
| Investor | Q1 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend